ScinoPharm Taiwan to invest in U.S. Tanvex Biologics
ScinoPharm, a Taiwan-based API maker invested Tanvex Biologics, expanding presence in US biosimilars contracting market.
Archives for August 31, 2010
TiGenix to spin-out drug discovery activities as Arcarios
TiGenix to spin-out its discovery and development business as new small-molecule focused industry-academia consortium Arcarios.